A systematic review identified nursing tips for the care of pediatric patients at risk of cytokine release syndrome after blinatumomab or CAR-T therapy.
The genomic-adjusted radiation dose (GARD) model predicts outcomes of radiotherapy.
Researchers studied a total of 1903 cases of pediatric melanoma and patients were 54.4% female, the mean age was 12.4 years, and 89.8% were White.
Adding temozolomide to vincristine and irinotecan improved survival.
More studies are needed to confirm if there is an effect on survival, according to researchers.
Testing revealed therapeutically relevant information for some patients.
Researchers studied a total of 1903 cases of pediatric melanoma and patients were 54.4% female, the mean age was 12.4 years, and 89.8% were White.
The rCOJEC regimen was less toxic than the MSKCC-N5 regimen.
Frail survivors of childhood cancer experienced greater neurocognitive decline.
Looking at single year of age revealed “substantial” differences.
